MedPath

Respiralab S.A.

🇪🇨Ecuador
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:0
Completed:2

Trial Phases

1 Phases

Not Applicable:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Not Applicable
1 (100.0%)

Efficacy and Safety of Phototherapy in the Treatment of Loss of Smell Post Acute Infection of Coronavirus 19

Not Applicable
Conditions
Smell Disorders
First Posted Date
2022-01-04
Last Posted Date
2022-01-04
Lead Sponsor
Respiralab
Target Recruit Count
40
Registration Number
NCT05177445
Locations
🇪🇨

Respiralab Research Group, Guayaquil, Guayas, Ecuador

OSA (oRisk of Obstructive Sleep Apnea and Traffic Accidents Among Bus Drivers in Ecuador: is There a Significant Association

Completed
Conditions
Sleep Apnea, Obstructive
First Posted Date
2022-01-03
Last Posted Date
2022-01-03
Lead Sponsor
Respiralab
Target Recruit Count
340
Registration Number
NCT05175287
Locations
🇪🇨

Respiralab Research Group, Guayaquil, Guayas, Ecuador

Adverse Reactions Following COVID-19 Vaccination Among Ecuadorian Healthcare Workers

Completed
Conditions
Adverse Drug Event
First Posted Date
2021-11-09
Last Posted Date
2021-11-09
Lead Sponsor
Respiralab
Target Recruit Count
1291
Registration Number
NCT05113472
Locations
🇪🇨

Universidad Espiritu Santo, Samborondon, Ecuador

News

No news found
© Copyright 2025. All Rights Reserved by MedPath